E-LIB Suche - Ergebnisse für: Evangelia S. Makri

1

Circulating leptin in patients with nonalcoholic fatty live..:

Makri, Evangelia S. ; Evripidou, Kleo ; Polyzos, Stergios A.
Journal of Gastroenterology and Hepatology. 39 (2024) 5 - p. 806-817 , 2024

Link: https://doi.org/10.1111/..

2

Partial validation of a six-month high-fat diet and fructos..:

Makri, Evangelia S. ; Xanthopoulos, Konstantinos ; Mavrommatis Parasidis, Panagiotis...
Endocrine. , 2024

Link: https://doi.org/10.1007/..

3

Circulating Ferritin in Patients with Nonalcoholic Fatty Li..:

Makri, Eleftheria ; Orfanidou, Myrsini ; Makri, Evangelia S....
Journal of Clinical and Experimental Hepatology. 14 (2024) 3 - p. 101353 , 2024

Link: https://doi.org/10.1016/..

4

Animal studies of sodium-glucose co-transporter 2 inhibitor..:

Makri, Evangelia S.
Annals of Gastroenterology. , 2024

Link: https://doi.org/10.20524..

5

Combination Therapies for Nonalcoholic Fatty Liver Disease:

Makri, Evangelia S. ; Makri, Eleftheria ; Polyzos, Stergios A.
Journal of Personalized Medicine. 12 (2022) 7 - p. 1166 , 2022

Link: https://doi.org/10.3390/..

6

Circulating adiponectin in patients with nonalcoholic fatty..:

Tontikidou, Christina ; Makri, Evangelia S ; Evripidou, Kleo...
Journal of Gastroenterology and Hepatology. 37 (2022) 10 - p. 1853-1864 , 2022

Link: https://doi.org/10.1111/..

7

Sodium-glucose co-transporter 2 inhibitors in nonalcoholic ..:

Makri, Evangelia S. ; Goulas, Antonis ; Polyzos, Stergios A.
European Journal of Pharmacology. 907 (2021) - p. 174272 , 2021

Link: https://doi.org/10.1016/..

8

An association study of the PNPLA3 I148M polymorphism (rs73..:

Despoina Ioannidou ; Evangelia S. Makri ; Stergios A. Polyzos...
https://www.explorationpub.com/Journals/em/Article/1001121. , 2023

Link: https://doi.org/10.37349..

9

Combination Therapies for Nonalcoholic Fatty Liver Disease:

Evangelia S. Makri ; Eleftheria Makri ; Stergios A. Polyzos
https://www.mdpi.com/2075-4426/12/7/1166. , 2022

Link: https://doi.org/10.3390/..

10

Combination Therapies for Nonalcoholic Fatty Liver Disease:

Makri, Evangelia S ; Makri, Eleftheria ; Polyzos, Stergios A
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322793/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Combination Therapies for Nonalcoholic Fatty Liver Disease:

Evangelia S. Makri ; Eleftheria Makri ; Stergios A. Polyzos
Clinical Medicine, Cell, and Organism Physiology. , 2022

Link: https://doi.org/10.3390/..

12

The potential of organic substrates based on mushroom subst..:

Karas, Panagiotis A. ; Makri, Sotirina ; Papadopoulou, Evangelia S....
Ecotoxicology and Environmental Safety. 124 (2016) - p. 447-454 , 2016

Link: https://doi.org/10.1016/..

13

PB1855: LACK OF MUTATIONS IN TNFRSF13B (TACI) IN PATIENTS W..:

Giannakoulas, N. ; Georgiadi, E. ; Makri, S....
HemaSphere. 6 (2022) - p. 1735-1736 , 2022

Link: https://doi.org/10.1097/..

14

Encephalite 3*3 : 3 générations, 3 tableaux, 3 diagnostics:

Talaboulma, I. ; Maguenouche, S.L. ; Benalia, R....
Revue Neurologique. 176 (2020) - p. S33-S34 , 2020

Link: https://doi.org/10.1016/..

15

Radiotherapy (RT) innovative Technology combined with Hospi..:

Spyropoulos, B. ; Adamopoulou, M. ; Arbis, S....
HNPS Proceedings. 24 (2019) - p. 85 , 2019

Link: https://doi.org/10.12681..